Literature DB >> 9409841

The sampling distribution of disease-associated alleles.

M Slatkin1, B Rannala.   

Abstract

A theory is developed that provides the sampling distribution of low frequency alleles at a single locus under the assumption that each allele is the result of a unique mutation. The numbers of copies of each allele is assumed to follow a linear birth-death process with sampling. If the population is of constant size, standard results from theory of birth-death processes show that the distribution of numbers of copies of each allele is logarithmic and that the joint distribution of numbers of copies of k alleles found in a sample of size n follows the Ewens sampling distribution. If the population from which the sample was obtained was increasing in size, if there are different selective classes of alleles, or if there are differences in penetrance among alleles, the Ewens distribution no longer applies. Likelihood functions for a given set of observations are obtained under different alternative hypotheses. These results are applied to published data from the BRCA1 locus (associated with early onset breast cancer) and the factor VIII locus (associated with hemophilia A) in humans. In both cases, the sampling distribution of alleles allows rejection of the null hypothesis, but relatively small deviations from the null model can account for the data. In particular, roughly the same population growth rate appears consistent with both data sets.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409841      PMCID: PMC1208351     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  4 in total

1.  The sampling theory of selectively neutral alleles.

Authors:  W J Ewens
Journal:  Theor Popul Biol       Date:  1972-03       Impact factor: 1.570

2.  The reconstructed evolutionary process.

Authors:  S Nee; R M May; P H Harvey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1994-05-28       Impact factor: 6.237

3.  Characterization of the human factor VIII gene.

Authors:  J Gitschier; W I Wood; T M Goralka; K L Wion; E Y Chen; D H Eaton; G A Vehar; D J Capon; R M Lawn
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

4.  A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Authors:  D Shattuck-Eidens; M McClure; J Simard; F Labrie; S Narod; F Couch; K Hoskins; B Weber; L Castilla; M Erdos
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

  4 in total
  7 in total

1.  Are rare variants responsible for susceptibility to complex diseases?

Authors:  J K Pritchard
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

2.  Determinants of Genetic Diversity of Spontaneous Drug Resistance in Bacteria.

Authors:  Alejandro Couce; Alexandro Rodríguez-Rojas; Jesús Blázquez
Journal:  Genetics       Date:  2016-05-10       Impact factor: 4.562

3.  Population genetic structure of sexual and parthenogenetic damselflies inferred from mitochondrial and nuclear markers.

Authors:  M O Lorenzo-Carballa; H Hadrys; A Cordero-Rivera; J A Andrés
Journal:  Heredity (Edinb)       Date:  2011-09-14       Impact factor: 3.821

Review 4.  "Personalizing" academic medicine: opportunities and challenges in implementing genomic profiling.

Authors:  David J Tweardy; John W Belmont
Journal:  Transl Res       Date:  2009-10-06       Impact factor: 7.012

5.  Likelihood models of somatic mutation and codon substitution in cancer genes.

Authors:  Ziheng Yang; Simon Ro; Bruce Rannala
Journal:  Genetics       Date:  2003-10       Impact factor: 4.562

6.  Detecting negative selection on recurrent mutations using gene genealogy.

Authors:  Kiyoshi Ezawa; Giddy Landan; Dan Graur
Journal:  BMC Genet       Date:  2013-05-07       Impact factor: 2.797

7.  Reflections on the Field of Human Genetics: A Call for Increased Disease Genetics Theory.

Authors:  Steven J Schrodi
Journal:  Front Genet       Date:  2016-06-08       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.